HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
复制标题
DOI:
10.1002/advs.202302025
复制
发表时间:
2023-09
期刊:
影响因子:
15.1
通讯作者:
Huang, Hongbiao
中科院分区:
文献类型:
--
作者:
Liao, Yuning;Liu, Yuan;Yu, Cuifu;Lei, Qiucheng;Cheng, Ji;Kong, Weiyao;Yu, Yuanhui;Zhuang, Xuefen;Sun, Wenshuang;Yin, Shusha;Cai, Gengxi;Huang, Hongbiao
YTH domain family 2 (YTHDF2) is the first identified N6‐methyladenosine (m6A) reader that regulates the status of mRNA. It has been reported that overexpressed YTHDF2 promotes carcinogenesis; yet, its role in hepatocellular carcinoma (HCC) is elusive. Herein, it is demonstrated that YTHDF2 is upregulated and can predict poor outcomes in HCC. Decreased ubiquitination levels of YTHDF2 contribute to the upregulation of YTHDF2. Furthermore, heat shock protein 90 beta (HSP90β) and STIP1 homology and U‐box‐containing protein 1 (STUB1) physically interact with YTHDF2 in the cytoplasm. Mechanically, the large and small middle domain of HSP90β is required for its interaction with STUB1 and YTHDF2. HSP90β inhibits the STUB1‐induced degradation of YTHDF2 to elevate the expression of YTHDF2 and to further boost the proliferation and sorafenib resistance of HCC. Moreover, HSP90β and YTHDF2 are upregulated, while STUB1 is downregulated in HCC tissues. The expression of HSP90β is positively correlated with the YTHDF2 protein level, whereas the expression of STUB1 is negatively correlated with the protein levels of YTHDF2 and HSP90β. These findings deepen the understanding of how YTHDF2 is regulated to drive HCC progression and provide potential targets for treating HCC. This study explores the ubiquitination of the N6‐methyladenosine (m6A) reader, YTH domain family 2 (YTHDF2). Heat shock protein 90 beta (HSP90β) promotes the progression of hepatocellular carcinoma (HCC) by suppressing STIP1 homology and U‐box‐containing protein 1 (STUB1)‐induced YTHDF2 ubiquitination, which may inaugurate a novel intervention strategy for the treatment of HCC.
登录
查看更多内容
影响因子:
25.7
作者:
Fujiwara N;Friedman SL;Goossens N;Hoshida Y
通讯作者:
Hoshida Y
影响因子:
11.2
作者:
Luan H;Mohapatra B;Bielecki TA;Mushtaq I;Mirza S;Jennings TA;Clubb RJ;An W;Ahmed D;El-Ansari R;Storck MD;Mishra NK;Guda C;Sheinin YM;Meza JL;Raja S;Rakha EA;Band V;Band H
通讯作者:
Band H
影响因子:
21.3
作者:
Connell, P;Ballinger, CA;Patterson, C
通讯作者:
Patterson, C
影响因子:
10.9
作者:
Chen X;Zhou X;Wang X
通讯作者:
Wang X
影响因子:
28.2
作者:
Dixit D;Prager BC;Gimple RC;Poh HX;Wang Y;Wu Q;Qiu Z;Kidwell RL;Kim LJY;Xie Q;Vitting-Seerup K;Bhargava S;Dong Z;Jiang L;Zhu Z;Hamerlik P;Jaffrey SR;Zhao JC;Wang X;Rich JN
通讯作者:
Rich JN